* Orthofix Medical Inc OFIX.OQ reported a quarterly
adjusted
loss of 10 cents per share for the quarter ended in March. The
mean expectation of three analysts for the quarter was for a
loss of 51 cents per share.
* Revenue rose 64.6% to $175.20 million from a year ago;
analysts
expected $168.46 million.
* Orthofix Medical Inc's reported EPS for the quarter was a
loss
of $1.71.
* The mean earnings estimate of analysts had fallen by
about 375.7% in the last three months.
* In the last 30 days, one analyst negatively revised an
earnings
estimate
* Orthofix Medical Inc shares had risen by 11.1% this
quarter and
lost 9.4% so far this year.
* The company reported a quarterly loss of $60.94 million.
* Wall Street's median 12-month price target for Orthofix
Medical
Inc is $37.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data May
9 at 10:01 p.m. UTC. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2023 -0.51 -0.10 Beat
Dec. 31 2022 0.10 0.19 Beat
Sep. 30 2022 0.12 0.13 Beat
Jun. 30 2022 0.10 0.08 Missed